Outlook Therapeutics, Inc. (OTLK:NASDAQ) closed at $0.436 on November 6, 2026, down 0.61% on the day. The stock trades 82.8% below its 52-week high of $2.54 and 171.1% above its 52-week low of $0.161. Over the past year, it lost 63.3%. Outlook Therapeutics, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since November 6, 2025, OTLK closed higher on 109 days (43%). Its best day was May 27, 2026 (+46.50%) and its worst was January 2, 2026 (-58.23%). The stock moved 10% or more in a single session 43 times. It opened at least 5% above the previous day's high 5 times.
Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.
Find more stocks like OTLK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.